Literature DB >> 8825060

Familial predisposition to both male and female germ cell tumours?

R A Huddart, C Thompson, R Houlston, R A Huddart, E J Nicholls, A Horwich.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8825060      PMCID： PMC1051823          DOI： 10.1136/jmg.33.1.86

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  An unusual case of gonadic germinal tumor in a brother and sister.

Authors:  G P Trentini; B Palmieri
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

2.  Ovarian dysgerminoma in three generations?

Authors:  S M Jackson
Journal:  J Med Genet       Date:  1967-06       Impact factor: 6.318

3.  Occurrence of seminoma and dysgerminoma in father and daughter.

Authors:  S M Yule; P J Dawes; A J Malcolm; A D Pearson
Journal:  Pediatr Hematol Oncol       Date:  1994 Mar-Apr       Impact factor: 1.969

4.  Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

Authors:  D Forman; R T Oliver; A R Brett; S G Marsh; J H Moses; J G Bodmer; C E Chilvers; M C Pike
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640
  4 in total
  3 in total

1.  Family history of cancer and malignant germ cell tumors in children: a report from the Children's Oncology Group.

Authors:  Jenny N Poynter; Amy H Radzom; Logan G Spector; Susan Puumala; Leslie L Robison; Zhi Chen; Julie A Ross; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2009-10-15       Impact factor: 2.506

Review 2.  A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.

Authors:  Claudia Giambartolomei; Christine M Mueller; Mark H Greene; Larissa A Korde
Journal:  Cancer Epidemiol       Date:  2009-05-30       Impact factor: 2.984

Review 3.  Human germ cell tumours from a developmental perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2019-08-14       Impact factor: 60.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.